Stephen Gottschalk spends much of his time researching Immunology, Antigen, Immunotherapy, Cytotoxic T cell and Adoptive cell transfer. The various areas that he examines in his Immunology study include Hematopoietic stem cell transplantation and Virology. Stephen Gottschalk combines subjects such as Cancer research, Oncology, Virus, Internal medicine and Chimeric antigen receptor with his study of Antigen.
His biological study deals with issues like Pathology, which deal with fields such as Stem cell. His study in Antigen-presenting cell and CTL* is done as part of Cytotoxic T cell. Stephen Gottschalk has included themes like ELISPOT and Interleukin 21 in his Adoptive cell transfer study.
Stephen Gottschalk focuses on Immunology, Antigen, Immunotherapy, Cancer research and Cytotoxic T cell. In his study, Oncology is strongly linked to Hematopoietic stem cell transplantation, which falls under the umbrella field of Immunology. His Antigen research incorporates elements of T cell, Molecular biology and Virus, Virology.
His Immunotherapy research integrates issues from Epitope, Adoptive cell transfer and Chemotherapy. His Cancer research research includes themes of Receptor and Tumor antigen. His studies deal with areas such as Epstein–Barr virus, Cancer immunotherapy and Lymphoma as well as Cytotoxic T cell.
Stephen Gottschalk mainly investigates Cancer research, Immunology, Antigen, Chimeric antigen receptor and Immunotherapy. His Cancer research study combines topics in areas such as Car t cells and Antibody. The Immunology study combines topics in areas such as Hematopoietic stem cell transplantation, Stem cell and Genetically modified organism.
His research ties PRAME and Antigen together. The concepts of his Chimeric antigen receptor study are interwoven with issues in Cytokine, Virology, A549 cell, Cytotoxic T cell and Glioblastoma. His Immunotherapy research focuses on subjects like Receptor, which are linked to Chemotherapy.
Chimeric antigen receptor, Immunology, Cancer research, Immunotherapy and Cytotoxic T cell are his primary areas of study. The Chimeric antigen receptor study which covers Cytokine that intersects with Adoptive cell transfer. His research investigates the connection between Immunology and topics such as A549 cell that intersect with issues in Adenoviridae and Leukemia.
His Cancer research study frequently draws parallels with other fields, such as Antigen. His work deals with themes such as Receptor, Oncology and T cell, which intersect with Antigen. His Immunotherapy study is concerned with the larger field of Cancer.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Human Epidermal Growth Factor Receptor 2 (HER2) –Specific Chimeric Antigen Receptor–Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma
Nabil Ahmed;Vita S. Brawley;Meenakshi Hegde;Catherine Robertson.
Journal of Clinical Oncology (2015)
Post-transplant lymphoproliferative disorders.
Stephen Gottschalk;Cliona M. Rooney;Helen E. Heslop.
Annual Review of Medicine (2005)
Design and development of therapies using chimeric antigen receptor-expressing T cells
Gianpietro Dotti;Stephen Gottschalk;Barbara Savoldo;Malcolm K. Brenner.
Immunological Reviews (2014)
Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape
Meenakshi Hegde;Malini Mukherjee;Malini Mukherjee;Zakaria Grada;Antonella Pignata.
Journal of Clinical Investigation (2016)
HER2-Specific Chimeric Antigen Receptor–Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial
Nabil Ahmed;Nabil Ahmed;Vita Brawley;Vita Brawley;Meenakshi Hegde;Meenakshi Hegde;Kevin Bielamowicz.
JAMA Oncology (2017)
Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane Proteins
Catherine M. Bollard;Catherine M. Bollard;Stephen Gottschalk;Stephen Gottschalk;Vicky Torrano;Vicky Torrano;Oumar Diouf;Oumar Diouf.
Journal of Clinical Oncology (2014)
TanCAR: A Novel Bispecific Chimeric Antigen Receptor for Cancer Immunotherapy
Zakaria Grada;Zakaria Grada;Meenakshi Hegde;Meenakshi Hegde;Tiara Byrd;Tiara Byrd;Donald R Shaffer;Donald R Shaffer.
Molecular therapy. Nucleic acids (2013)
A novel DNA-peptide complex for efficient gene transfer and expression in mammalian cells.
S. Gottschalk;J. T. Sparrow;J. Hauer;M. P. Mims.
Gene Therapy (1996)
HER2-Specific T Cells Target Primary Glioblastoma Stem Cells and Induce Regression of Autologous Experimental Tumors
Nabil Ahmed;Vita S. Salsman;Yvonne Kew;Donald Shaffer.
Clinical Cancer Research (2010)
Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer.
Catherine M. Bollard;Stephen Gottschalk;Ann M. Leen;Heidi Weiss.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: